266 related articles for article (PubMed ID: 2955037)
1. Cyclosporine-induced tolerance in experimental organ transplantation. Evidence of diminished donor-specific cytotoxicity relative to donor-specific proliferative response.
Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
J Immunol; 1987 Jul; 139(2):332-7. PubMed ID: 2955037
[TBL] [Abstract][Full Text] [Related]
2. Evidence of intragraft interleukin-2-activated killer cells and allospecific cytolytic T lymphocytes in rejecting lung allografts.
Norin AJ; Kamholz SL
Transplantation; 1989 Nov; 48(5):856-62. PubMed ID: 2530670
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
Vandekerckhove BA; Datema G; Koning F; Goulmy E; Persijn GG; Van Rood JJ; Claas FH; De Vries JE
J Immunol; 1990 Feb; 144(4):1288-94. PubMed ID: 2137487
[TBL] [Abstract][Full Text] [Related]
4. Concanavalin A-dependent cell-mediated cytotoxicity in bronchoalveolar lavage fluid. Correlation with lung allograft rejection in mongrel dogs during cyclosporine dose tapering.
Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
Transplantation; 1986 Nov; 42(5):466-72. PubMed ID: 3538531
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion.
Quigley RL; Wood KJ; Morris PJ
Immunology; 1988 Mar; 63(3):373-81. PubMed ID: 2965097
[TBL] [Abstract][Full Text] [Related]
6. The immunobiology of experimental lung transplantation with cyclosporine immunosuppression: cytolytic T lymphocytes and delayed type hypersensitivity in rejecting and tolerant recipients.
Norin AJ
Transplant Proc; 1988 Apr; 20(2 Suppl 2):125-30. PubMed ID: 2966476
[No Abstract] [Full Text] [Related]
7. Activation of donor-specific CTL in a tolerant recipient of cardiac allograft.
Petersson E; Qi Z; Hedlund G; Ekberg H
Cell Immunol; 1998 Oct; 189(1):19-24. PubMed ID: 9758690
[TBL] [Abstract][Full Text] [Related]
8. Peripheral tolerance to class I mismatched renal allografts in miniature swine: donor antigen-activated peripheral blood lymphocytes from tolerant swine inhibit antidonor CTL reactivity.
Ierino FL; Yamada K; Hatch T; Rembert J; Sachs DH
J Immunol; 1999 Jan; 162(1):550-9. PubMed ID: 9886432
[TBL] [Abstract][Full Text] [Related]
9. Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactions.
Hooton JW; Miller CL; Helgason CD; Bleackley RC; Gillis S; Paetkau V
J Immunol; 1990 Feb; 144(3):816-23. PubMed ID: 2136900
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.
Fink PJ; Rammensee HG; Benedetto JD; Staerz UD; Lefrancois L; Bevan MJ
J Immunol; 1984 Oct; 133(4):1769-74. PubMed ID: 6236258
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to class II major histocompatibility complex molecules is maintained in the presence of endogenous, interleukin-2-producing, tolerogen-specific T lymphocytes.
Mohler KM; Streilein JW
J Immunol; 1987 Oct; 139(7):2211-9. PubMed ID: 2958541
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
Havele C; Paetkau V
J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
[TBL] [Abstract][Full Text] [Related]
13. Antigen-independent activation of memory cytotoxic T cells by interleukin 2.
Lefrancois L; Klein JR; Paetkau V; Bevan MJ
J Immunol; 1984 Apr; 132(4):1845-50. PubMed ID: 6230394
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytolytic T lymphocyte maturation with ornithine, arginine, and putrescine.
Susskind BM; Chandrasekaran J
J Immunol; 1987 Aug; 139(3):905-12. PubMed ID: 2955052
[TBL] [Abstract][Full Text] [Related]
15. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient.
Burlingham WJ; Grailer AP; Fechner JH; Kusaka S; Trucco M; Kocova M; Belzer FO; Sollinger HW
Transplantation; 1995 Apr; 59(8):1147-55. PubMed ID: 7732562
[TBL] [Abstract][Full Text] [Related]
16. In vivo mechanisms of alloreactivity. II. Allospecificity of cytotoxic T lymphocytes in sponge matrix allografts as determined by limiting dilution analysis.
Orosz CG; Zinn NE; Sirinek LP; Ferguson RM
Transplantation; 1986 Jan; 41(1):84-92. PubMed ID: 2934879
[TBL] [Abstract][Full Text] [Related]
17. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
Isakov N; Bach FH
J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
[TBL] [Abstract][Full Text] [Related]
18. Hydrocortisone suppresses the generation of nonspecific "anomalous" killers but not specific cytolytic T lymphocytes in human mixed lymphocyte-tumor cultures.
Muul LM; Gately MK
J Immunol; 1984 Mar; 132(3):1202-7. PubMed ID: 6198383
[TBL] [Abstract][Full Text] [Related]
19. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
20. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
Williams IR; Perry LL
J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
